Tela Bio is a medical devices business based in the US. Tela Bio shares (TELA) are listed on the NASDAQ and all prices are listed in US Dollars. Tela Bio employs 227 staff and has a trailing 12-month revenue of around $64.7 million.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $2.72 |
|---|---|
| 52-week range | $2.54 - $9.60 |
| 50-day moving average | $4.13 |
| 200-day moving average | $5.42 |
| Wall St. target price | $10.80 |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $-1.70 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $2.72 from 2024-09-04
| 1 week (2024-08-30) | -6.21% |
|---|---|
| 1 month (2024-08-06) | -35.24% |
| 3 months (2024-06-06) | -52.45% |
| 6 months (2024-03-06) | -57.50% |
| 1 year (2023-09-06) | -71.37% |
|---|---|
| 2 years (2022-09-06) | -69.37% |
| 3 years (2021-09-03) | 13.02 |
| 5 years (2019-09-02) | N/A |
| Revenue TTM | $64.7 million |
|---|---|
| Gross profit TTM | $27.8 million |
| Return on assets TTM | -37.55% |
| Return on equity TTM | -196.42% |
| Profit margin | -65.04% |
| Book value | $0.12 |
| Market Capitalization | $71.7 million |
TTM: trailing 12 months
We're not expecting Tela Bio to pay a dividend over the next 12 months.
Over the last 12 months, Tela Bio's shares have ranged in value from as little as $2.535 up to $9.6. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Tela Bio's is 0.994. This would suggest that Tela Bio's shares are less volatile than average (for this exchange).
TELA Bio, Inc. , a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. The company was incorporated in 2012 and is headquartered in Malvern, Pennsylvania. .
Use this calculator to quickly see potential outcomes of your options trades.
SoFi, Robinhood, Tastytrade, Webull, Interactive Brokers, E*TRADE, eToro and others top our list for the best options trading platforms.
A covered call is an options trading strategy that allows you to generate income from stocks you already own.
A look at GSD Capital’s highlights, limitations, fees and investment strategies.
Explore the best bonuses for opening a new brokerage account.
Looking for a discount broker like E*TRADE that offers something different? Here are some of the top alternatives to consider.
Charles Schwab and Fidelity are two powerhouse trading platforms for beginner and advanced investors.
Interactive Brokers has advanced charting tools but a high net requirement to qualify.
Discover the top tech stocks poised to lead innovation and offer substantial growth opportunities.
Learn about Wealthfront’s automated investing tools and services to see if it’s the right platform for you.